These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7725370)

  • 1. Modified enzyme-multiplied immunoassay technique valproic acid test kit.
    Meatherall R; Krahn J
    Ther Drug Monit; 1995 Feb; 17(1):104-5. PubMed ID: 7725370
    [No Abstract]   [Full Text] [Related]  

  • 2. Falsely elevated enzyme-multiplied immunoassay serum valproic acid results in 12 patients.
    Meatherall R; Krahn J
    Ther Drug Monit; 1993 Jun; 15(3):255-7. PubMed ID: 8333007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid estimation by enzyme immunoassay.
    Elyas AA; Goldberg VD; Ratnaraj N; Lascelles PT
    Ann Clin Biochem; 1980 Nov; 17(6):307-10. PubMed ID: 6782934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of phenytoin in serum using in-house reagents employing the Syva enzyme-multiplied immunoassay technique principle.
    Colbert DL
    Ther Drug Monit; 1992 Oct; 14(5):386-90. PubMed ID: 1448846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of increased Tn I measurements using different assays.
    Hawkins RC
    Clin Chim Acta; 2005 Apr; 354(1-2):213-4. PubMed ID: 15748621
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge system.
    Rambeck B; May TW; Jürgens MU; Blankenhorn V; Jürges U; Korn-Merker E; Sälke-Kellermann A
    Ther Drug Monit; 1994 Dec; 16(6):608-12. PubMed ID: 7878702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences with the enzyme-multiplied immunoassay cyclosporine specific assay in a therapeutic drug monitoring laboratory.
    Morris RG; Saccoia NC; Sallustio BC; Fergusson LK; Mangas S; Kassapidis C
    Ther Drug Monit; 1993 Oct; 15(5):410-3. PubMed ID: 8249048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence polarization immunoassay of quinidine, procainamide, and N-acetylprocainamide using Cobas-FP reagents.
    Lam YW; Watkins CE
    Clin Pharm; 1993 Jan; 12(1):49-52. PubMed ID: 7679064
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of postoperative cTnI in cardiac surgery: comparison of Abbott and Dade assays.
    Mongredien A; Provenchère S; Berroeta C; Verpillat P; Desmonts JM; Durand G; Philip I; Dehoux M
    Clin Chim Acta; 2005 Apr; 354(1-2):209-11. PubMed ID: 15748620
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzyme immunoassay of valproic acid using the Abbott ABA-200 analyzer.
    Higgins TN
    Clin Biochem; 1983 Aug; 16(4):222-3. PubMed ID: 6413089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of low serum methotrexate concentrations with the Syva Emit Methotrexate Assay.
    Demedts P; Vanden Wyngaerd A; Wauters A; Neels H
    Ther Drug Monit; 1997 Oct; 19(5):545-6. PubMed ID: 9357100
    [No Abstract]   [Full Text] [Related]  

  • 12. False-positive results with Emit II amphetamine/methamphetamine assay in users of common psychotropic drugs.
    Smith-Kielland A; Olsen KM; Christophersen AS
    Clin Chem; 1995 Jun; 41(6 Pt 1):951-2. PubMed ID: 7768025
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of DRI drug-of-abuse reagents on the Hitachi 911.
    Haver V; Black D; Garbin J
    J Anal Toxicol; 1998 Sep; 22(5):403-4. PubMed ID: 9737338
    [No Abstract]   [Full Text] [Related]  

  • 14. Unavailability of drug metabolite reference material to evaluate false-positive results for monoclonal EMIT-d.a.u. assay of amphetamine.
    Poklis A
    Clin Chem; 1992 Dec; 38(12):2560. PubMed ID: 1458603
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct single-reagent fluorescence polarisation immunoassay for valproic acid in serum.
    Sidki AM; Staley K; Boyes H; Landon J; Williams AH
    J Clin Chem Clin Biochem; 1988 Feb; 26(2):69-74. PubMed ID: 3130457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reagent lot-to-lot variability in sensitivity for amphetamine with the Syva Emit II Monoclonal Amphetamine/Methamphetamine assay.
    Singh J
    J Anal Toxicol; 1997; 21(2):174-5. PubMed ID: 9083839
    [No Abstract]   [Full Text] [Related]  

  • 17. [An evaluation of substrate-labeled fluorescent immunoassay (SLFIA method) by using pharmacokinetic parameters of valproic acid].
    Johno I; Nakamura T; Hasegawa M; Maeda M; Ogura Y; Kitazawa S
    Yakugaku Zasshi; 1986 Feb; 106(2):169-75. PubMed ID: 3086534
    [No Abstract]   [Full Text] [Related]  

  • 18. Interference of Gemfibrozil with Roche TesTcup.
    Lewis JH
    J Anal Toxicol; 1999 Sep; 23(5):384. PubMed ID: 10488928
    [No Abstract]   [Full Text] [Related]  

  • 19. A micro-enzyme-multiplied immunoassay technique plate assay for antiepileptic drugs.
    Tittle TV; Schaumann BA
    Ther Drug Monit; 1992 Apr; 14(2):159-63. PubMed ID: 1585403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falsely negative urine drug assay results due to filtration.
    Mitchell JD; Perrigo BJ; Mason-Daniel VA
    Clin Chem; 1992 Dec; 38(12):2556-7. PubMed ID: 1303644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.